TrademarkDir
HYPERZOL
LIVE

Serial Number

87699493

Owner

NuRemedy Pharma LLC

Attorney

Sean MacKenzie

First Use Date

Aug 18, 2020

Filing Date

Nov 28, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HYPERZOL Trademark

Serial Number: 87699493 • Registration: 6322522

HYPERZOL is a trademark filed by NuRemedy Pharma LLC on November 28, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NuRemedy Pharma LLC (6 trademarks)

1180 North Town Center, Suite 100
Las Vegas, NV 89144

Entity Type: 16

Nexzol Pharma, Inc. (9 trademarks)

1001 Avenida Pico, Suite C-501
San Clemente, CA 92673

Entity Type: 03

Trademark Details

Filing Date

November 28, 2017

Registration Date

April 13, 2021

First Use Anywhere

August 18, 2020

First Use in Commerce

August 18, 2020

Published for Opposition

April 24, 2018

Filing History

REGISTERED-PRINCIPAL REGISTER
Apr 13, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 6, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 5, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2021 TROA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 24, 2020 EXRA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 23, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 23, 2020 SUPC
SOU EXTENSION 4 GRANTED
Sep 23, 2020 EX4G
NOTICE OF REVIVAL - E-MAILED
Aug 19, 2020 NREV
USE AMENDMENT FILED
Aug 18, 2020 IUAF
SOU EXTENSION RECEIVED WITH TEAS PETITION
Aug 18, 2020 TPEX
PETITION TO REVIVE-GRANTED
Aug 18, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 18, 2020 PROA
TEAS STATEMENT OF USE RECEIVED
Aug 18, 2020 EISU
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 20, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 20, 2020 ABN6
SOU EXTENSION 4 FILED
Jun 19, 2020 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2019 EXRA
SOU EXTENSION 3 GRANTED
Dec 12, 2019 EX3G
SOU EXTENSION 3 FILED
Dec 12, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 12, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2019 EXRA
SOU EXTENSION 2 GRANTED
Aug 27, 2019 EX2G
NOTICE OF REVIVAL - E-MAILED
Jul 25, 2019 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 24, 2019 TPEX
PETITION TO REVIVE-GRANTED
Jul 24, 2019 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 24, 2019 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 22, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 22, 2019 ABN6
SOU EXTENSION 2 FILED
Jun 19, 2019 EXT2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2019 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 3, 2019 EXRA
SOU EXTENSION 1 GRANTED
Jan 2, 2019 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 2, 2019 AITU
SOU EXTENSION 1 FILED
Dec 17, 2018 EXT1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2018 TCCA
SOU TEAS EXTENSION RECEIVED
Dec 17, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 19, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2018 NONP
ASSIGNED TO LIE
Mar 18, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 12, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 12, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 12, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 12, 2018 CNEA
ASSIGNED TO EXAMINER
Mar 12, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2017 NWOS
NEW APPLICATION ENTERED
Dec 1, 2017 NWAP

Related Trademarks

More from this Owner

NEXREMEDY

NEXREMEDY

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL